EP3672595
COMBINATION PRODUCT OF BCL-2 INHIBITOR AND CHEMOTHERAPEUTIC AGENT AND USE THEREOF IN THE PREVENTION AND/OR TREATMENT OF DISEASES
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
22.7.2019EP published:
21.7.2021EP application number:
19843524.0
EPO information:
European Patent Register
Max expiry date:
21.7.2039
Title:
COMBINATION PRODUCT OF BCL-2 INHIBITOR AND CHEMOTHERAPEUTIC AGENT AND USE THEREOF IN THE PREVENTION AND/OR TREATMENT OF DISEASES
Timeline
Today
22.7.2019EP application
21.7.2021EP Publication
Owner
Name:
Ascentage Pharma (Suzhou) Co., Ltd.Address:
Unit 701, Building B7, 218 Xinghu Street Suzhou Industrial Park, Suzhou, Jiangsu 215000, CN
Inventor
Name:
YANG, DajunAddress:
Suzhou, Jiangsu 215000, CN
Name:
ZHAI, YifanAddress:
Suzhou, Jiangsu 215000, CN
Name:
WANG, GuangfengAddress:
Suzhou, Jiangsu 215000, CN
Priority
Number:
201810862169Date:
31.7.2018Country:
CN
Classification
Categories:
A61K 31/4745, A61K 31/496, A61K 31/497, A61K 31/00, A61P 35/00, A61P 35/02, A61K 31/635, A61K 9/00, A61K 9/16, A61K 9/20, A61K 9/48, A61K 45/06, C07D 471/04